Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study

BACKGROUND: The ten-valent pneumococcal conjugate vaccine (PCV10) was introduced into the Finnish National Vaccination Program (NVP) in September 2010 using a 2+1 schedule (3, 5, 12 months). We estimated the direct and indirect effects of PCV10 on pneumonia among children to evaluate the public heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmu, Arto A., Rinta-Kokko, Hanna, Nohynek, Hanna, Nuorti, J. Pekka, Kilpi, Terhi M., Jokinen, Jukka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332024/
https://www.ncbi.nlm.nih.gov/pubmed/28249015
http://dx.doi.org/10.1371/journal.pone.0172690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5332024/
https://www.ncbi.nlm.nih.gov/pubmed/28249015
http://dx.doi.org/10.1371/journal.pone.0172690

Ejemplares similares